Article

Retina Roundtable Session 1

Subscribe

In this first session, the experts discuss their standard approach when using ranibizumab (Lucentis, Genentech) to treat their patients with age-related macular degeneration.

Participants include:

Return to Retina Roundtable Podcast Series

Return to Ophthalmology Times Radio

Related Videos
Image credit: Ophthalmology Times; Angiogenesis 2025: Encapsulated cell therapy for MacTel shows long-term efficacy in phase 3 trials
Image credit: Ophthalmology Times; Dean McGee Eye Institute resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
© 2025 MJH Life Sciences

All rights reserved.